3 posts tagged

long-acting injectable HIV pre-exposure prophylaxis

  

On the CUSP: July 2024

August 2, 2024 by | Pharmacy

Awards and Recognitions Dr. Jeff Goad was installed as President of the National Foundation for Infectious Diseases on July 1, 2024. Quotables (Faculty in the News) Dr. Cintia Citterio was quoted in Endocrine News: 2024 Researchers Roundtable, discussing endocrine science with the other 2024 Early Investigator Award winners. Dr. Jeff Goad was quoted in a Pharmacy Times

Evaluating Pharmacists’ Readiness for Long-Acting Injectable HIV Prevention

July 22, 2024 by | Research

Chapman University’s Dr. Jerika Lam and CSHP‘s CEO Dr. Loriann De Martini co-published “A mixed methods evaluation of pharmacists’ readiness to provide long-acting injectable HIV pre-exposure prophylaxis in California” in the Journal of Acquired Immune Deficiency Syndromes (JAIDS). The study investigated the underlying causes for why HIV prevention medication, pre-exposure prophylaxis (PrEP), isn’t widely used

On the CUSP: June 2024

July 2, 2024 by | Research

Grants Dr. Ajay Sharma has received a grant from the National Eye Institute for his project, “Targeting the multicellular process of corneal regeneration and vascularization to enhance outcome of cornea transplantation”. He, alongside other investigators, will test the effect of topical application of a recombinant protein Mitsugumin 53 (MG53) on enhancing the success of corneal

Log In
Open Main Menu